ZyVersa Therapeutics, Inc. — All Filings
314 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-008994 | Mar 5, 2026 | Feb 27, 2026 |
| 8-K | 8-K | 0001493152-25-025966 | Dec 3, 2025 | Dec 2, 2025 |
| 8-K | 8-K | 0001493152-25-024273 | Nov 19, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-024263 | Nov 19, 2025 | Sep 30, 2025 |
| NT 10-Q | NT 10-Q | 0001493152-25-023612 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-018156 | Oct 15, 2025 | Oct 10, 2025 |
| 25-NSE | — | 0001354457-25-000988 | Oct 6, 2025 | — |
| 8-K | 8-K | 0001493152-25-013968 | Sep 18, 2025 | Sep 14, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-003603 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-023342 | Aug 13, 2025 | Jun 30, 2025 |
| EFFECT | — | 9999999995-25-002497 | Aug 6, 2025 | — |
| CORRESP | — | 0001641172-25-022236 | Aug 5, 2025 | — |
| CORRESP | — | 0001641172-25-021954 | Aug 1, 2025 | — |
| S-1/A | S-1/A | 0001641172-25-021952 | Aug 1, 2025 | — |
| UPLOAD | — | 0000000000-25-008006 | Jul 30, 2025 | — |
| 8-K | 8-K | 0001641172-25-021100 | Jul 28, 2025 | Jul 25, 2025 |
| S-1/A | S-1/A | 0001641172-25-020253 | Jul 18, 2025 | — |
| 4 | — | 0001641172-25-019858 | Jul 16, 2025 | Jul 11, 2025 |
| 8-K | 8-K | 0001641172-25-019856 | Jul 16, 2025 | Jul 15, 2025 |
| 4 | — | 0001641172-25-019724 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019725 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019723 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019729 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019726 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019727 | Jul 15, 2025 | Jul 11, 2025 |
| 4 | — | 0001641172-25-019728 | Jul 15, 2025 | Jul 11, 2025 |
| 8-K | 8-K | 0001641172-25-018403 | Jul 9, 2025 | Jul 8, 2025 |
| S-1 | S-1 | 0001641172-25-017434 | Jul 2, 2025 | — |
| 8-K | 8-K | 0001641172-25-016388 | Jun 25, 2025 | Jun 24, 2025 |
| 8-K | 8-K | 0001641172-25-014895 | Jun 12, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0001641172-25-013038 | May 30, 2025 | May 27, 2025 |
| SCHEDULE 13G | — | 0001172661-25-002203 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-009724 | May 12, 2025 | Mar 31, 2025 |
| ARS | — | 0001641172-25-005245 | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | — | 0001641172-25-005244 | Apr 17, 2025 | — |
| DEF 14A | — | 0001641172-25-005242 | Apr 17, 2025 | — |
| EFFECT | — | 9999999995-25-001061 | Apr 9, 2025 | — |
| CORRESP | — | 0001641172-25-003293 | Apr 8, 2025 | — |
| UPLOAD | — | 0000000000-25-003762 | Apr 8, 2025 | — |
| PRE 14A | — | 0001641172-25-003036 | Apr 7, 2025 | — |
| 8-K | — | 0001641172-25-003034 | Apr 7, 2025 | Apr 4, 2025 |
| S-3 | — | 0001641172-25-002793 | Apr 4, 2025 | — |
| 10-K | — | 0001641172-25-000862 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | — | 0001493152-25-009571 | Mar 7, 2025 | Mar 4, 2025 |
| S-8 | — | 0001493152-25-003572 | Jan 24, 2025 | — |
| DEF 14A | — | 0001493152-25-002752 | Jan 17, 2025 | — |
| 424B3 | — | 0001493152-24-052402 | Dec 30, 2024 | — |
| EFFECT | — | 9999999995-24-003923 | Dec 26, 2024 | — |
| CORRESP | — | 0001493152-24-051958 | Dec 26, 2024 | — |
| UPLOAD | — | 0000000000-24-014226 | Dec 23, 2024 | — |